Iron-Deficiency Fatigue

Iron-Deficiency Fatigue

Definition and Overview

Iron-deficiency fatigue is the persistent, often debilitating sense of physical and mental exhaustion that arises as a direct consequence of insufficient iron in the body, occurring both in the context of frank iron-deficiency anemia (IDA) and — critically — in the pre-anemic state known as iron deficiency without anemia (IDWA), also called non-anemic iron deficiency (NAID). Iron deficiency without anaemia is a widespread health problem that often remains undetected; neurological and psychopathological problems such as fatigue and poor concentration are a major issue, and the exact pathogenesis is often unknown, though iron is known to be involved in several very important metabolic processes in the human body.

Iron is an essential component of the hemoglobin molecule, and the most common cause of anemia worldwide is iron deficiency, which results in microcytic, hypochromic red blood cells on peripheral smear. Beyond its hematological role, iron participates in a much wider range of cellular functions, and it is this systemic involvement that explains why fatigue and other functional symptoms can precede the development of measurable anemia. Symptoms may be absent or minimal in early or mild disease, and the rate of hemoglobin decline, age, and comorbidities influence the clinical picture; notably, iron deficiency without anemia can still cause symptoms such as fatigue, cognitive impairment, and restless leg syndrome.

Iron-deficiency anaemia currently affects 1.2 billion people, and iron deficiency without anaemia is at least twice as common; IDWA is poorly recognised by clinicians despite its high prevalence, probably because of suboptimal screening recommendations.

Presentation and Clinical Features

The majority of symptoms are nonspecific and can include, but are not limited to, generalized weakness, fatigue, poor concentration, mood changes, irritability, headaches, shortness of breath on exertion, dry mouth, hair loss, dysphagia, brittle fingernails, restless leg syndrome, and decreased exercise capacity; these symptoms are attributable to low oxygen delivery to tissues and reduced activity of iron-containing enzymes.

Individuals with nonanemic iron deficiency or iron-deficiency anemia may be asymptomatic or experience fatigue, irritability, depression, difficulty concentrating, restless legs syndrome (32–40%), pica (40–50%), dyspnea, lightheadedness, exercise intolerance, and worsening heart failure; symptom prevalences vary depending on age, comorbidities, and severity and rate of development of iron deficiency.

Physical findings, while often subtle, can include pallor, dry mouth, atrophic glossitis, angular cheilitis, and hair loss; chronic or severe cases may lead to koilonychia (spoon-shaped nails) and, rarely, Plummer–Vinson syndrome. Cardiovascular signs such as tachycardia, functional systolic murmur, and, in severe cases, syncope or heart failure exacerbation may be observed, particularly when anemia is profound or develops rapidly.

The symptom burden in IDWA can be significant even in the absence of anemia. One should always consider iron deficiency (without anemia) as the cause of persisting, unexplained unspecific, often severe symptoms, regardless of the primary underlying disease; the symptoms of iron deficiency may arise from the metabolic systems where many proteins are iron-containing. Hypothyroidism based on symptoms is indistinguishable from iron deficiency; fatigue and neurocognitive symptoms often raise a suspicion of depression; and headache and muscle and joint pain associated with iron deficiency are repeatedly considered migraine and fibromyalgia syndrome, respectively.

Symptoms that cause a loss of productivity — and a wide range of symptoms associated with iron deficiency — include fatigue, poor sleep, back pain, headaches, insomnia, and anxiety.

Body Systems Involved

Hematological System

Circulating red blood cells contain the protein hemoglobin, which has four polypeptide chains and one heme ring containing iron in its reduced form; iron is the main component of hemoglobin and is the prime carrier of oxygen. When iron stores become depleted, erythropoiesis is impaired and red blood cells become smaller and contain less hemoglobin. Red blood cells become smaller and contain less hemoglobin; as a result, blood carries less oxygen from the lungs throughout the body.

Musculoskeletal and Energy-Production Systems

Iron's role in fatigue extends beyond oxygen transport to the cellular machinery of energy production itself. Mechanisms linking iron deficiency to muscle fatigue are still poorly understood; the main hypothesis is that iron deficiency is responsible for an alteration of mitochondrial muscle metabolism, iron being present in both iron-sulfur centers and in cytochromes of the mitochondrial respiratory chain. This has been demonstrated experimentally: in iron-deficient mice, endurance was significantly reduced and activity of the respiratory chain complex I, normalized to citrate synthase activity, was significantly reduced in the soleus muscle; complex IV activities were not significantly different; these results suggest that iron deficiency without anemia is responsible for impaired mitochondrial complex I activity in skeletal muscles with predominant oxidative metabolism, bringing pathophysiological support to explain the improved physical activity observed when correcting iron deficiency in humans.

At the cellular level, cellular iron deficiency can lead to loss of activity of oxidative phosphorylation complexes I to IV in cells that are highly dependent on mitochondrial respiration. Iron is essential for many biochemical and metabolic processes, including mitochondrial respiration, oxidative phosphorylation, citric acid cycle, DNA synthesis, and hormone production.

Neurological System

The brain requires iron for mitochondrial respiration and synthesis of myelin, neurotransmitters, and monoamine oxidases. Iron is a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis; reduced activity of tyrosine hydroxylase — a central iron-dependent element of dopamine synthesis — is assumed to lead to deficiencies in dopaminergic function, contributing to fatigue and restless legs syndrome.

Non-erythropoietic symptoms relate to altered muscle mitochondrial function and electron transport chain, brain cell metabolism, neurotransmission, and neuroplasticity. Cognitive manifestations of iron-deficiency fatigue include decreased cognitive abilities, attention, and concentration. Restless leg syndrome is associated with decreased brain iron on magnetic resonance imaging, and up to 40% of patients with this condition may have iron deficiency, with or without anemia.

Immune System

Iron is necessary for the synthesis of hemoglobin and myoglobin, oxygen transport, hormone synthesis, cell regulation and proliferation, DNA synthesis, mitochondrial electron transport, and antioxidation; iron also plays a vital role in regulating both innate and adaptive immunity. Immune dysfunction resulting from iron deficiency can increase susceptibility to infections.

Cardiovascular System

In some populations such as heart failure patients, iron deficiency, likely through muscle fatigue, is also responsible for a deterioration of quality of life, a worsening of dyspnoea, and a worsening of the prognosis of heart failure. Undiagnosed or untreated iron-deficiency anemia may cause serious complications such as fatigue, headaches, restless legs syndrome, heart problems, pregnancy complications, and developmental delays in children.

Contributing and Associated Factors

Epidemiology and At-Risk Populations

Iron deficiency causes a profound global burden, affecting over 2 billion people worldwide; iron deficiency is estimated to affect about 40% of the population in developing countries and 10% in developed countries, making it the most common cause of anemia worldwide. Iron deficiency is a serious public health problem that affects 20–25% of the population and 52% of pregnant people worldwide; women of reproductive age have a higher risk of developing iron deficiency due to the increased physiologic demand for iron required to support menstruation and pregnancy.

In high-income countries, approximately 38% of nonpregnant, reproductive-age women have iron deficiency without anemia and about 13% have iron-deficiency anemia.

The European Hematology Association recommends screening individuals at high risk for iron deficiency, including athletes, vegetarians, frequent blood donors, reproductive-aged women, adults older than 65, individuals with malabsorptive syndromes or bleeding disorders, socioeconomically disadvantaged populations, individuals with chronic parasitic infections, and those with chronic diseases.

Blood Loss

The most common causes of iron deficiency are bleeding (menstrual, gastrointestinal), impaired iron absorption (atrophic gastritis, celiac disease, bariatric surgical procedures), inadequate dietary iron intake, and pregnancy. Iron deficiency remains one of the most common micronutrient deficiencies worldwide, affecting an estimated 1.2 billion individuals globally, with a particularly high prevalence among women of reproductive age; in women, iron deficiency is driven by multiple factors, including menstrual blood loss, dietary insufficiency, malabsorption, and reproductive demands such as pregnancy and lactation.

Dietary Insufficiency

Inadequate intake can result from iron-deficient diets, such as the increasingly popular vegan diets, or from having higher iron requirements, as seen in growing children and pregnant women. Dietary composition can affect body iron stocks because the intake of iron in the heme form has higher bioavailability than in the nonheme form.

Athletic Activity and Inflammation

Athletes and those performing in demanding sports have increased iron needs and are at a higher risk of developing iron deficiency, mainly due to chronic inflammation and increased losses; hepcidin levels are elevated in chronic inflammation, resulting in blockage of the only known iron exporter, ferroportin; additionally, athletes have greater iron losses through urine and sweat during vigorous activity.

Malabsorption

Medical conditions that interfere with iron absorption include celiac disease, Crohn's disease, malabsorptive disorders, and a history of gastric bypass surgery; patients with these disorders also have increased iron needs and often require supplementation to maintain adequate stores. A lifelong history of blood loss — such as abundant menstruation, pregnancies, blood donations, accidents/surgery — as well as history of celiac disease, atrophic gastritis, and drugs limiting gastric acid secretion, should be taken into account.

Comorbid Inflammatory Disease

It is unclear what impact iron deficiency has on fatigue in people with inflammatory bowel disease (IBD); systematic review evidence has examined whether iron deficiency, with or without anaemia, is associated with fatigue in IBD; fatigue is a common symptom in patients with IBD that can be difficult to manage and treat.

Diagnosis and Key Biomarkers

Diagnosis relies on laboratory assessment, typically with low hemoglobin and low ferritin, although ferritin is also elevated in the presence of inflammation. Iron deficiency and iron-deficiency anemia are common conditions that may cause symptoms such as fatigue, exercise intolerance, and difficulty concentrating; ferritin and/or transferrin saturation are required for diagnosis and screening.

Iron deficiency may be severe despite a normal hemoglobin and full blood count; symptoms that may be prolonged and debilitating should raise a clinical suspicion of iron deficiency even if the full blood count is normal. Absolute iron deficiency is a clinico-biological condition that associates a decrease in total body iron stores (ferritinemia below 30–50 µg/L, excluding a chronic inflammatory syndrome and hepatic cytolysis).

Nutrients Studied in Relation to Iron-Deficiency Fatigue

Iron Itself

The primary intervention studied for iron-deficiency fatigue is iron repletion. A landmark 2017 meta-analysis published in the British Journal of Nutrition specifically addressed whether iron therapy reduces fatigue in those without anemia. The meta-analysis evaluated the therapeutic effect of iron on fatigue in patients with IDNA and the association between IDNA and fatigue; articles from PubMed up to January 2016 were systematically searched; a total of six relevant randomised controlled trials and six relevant cross-sectional studies were identified; all outcomes were converted into effect sizes; the meta-analysis of the six RCTs identified a significant therapeutic effect of iron in fatigue patients with IDNA (pooled effect size 0.33; 95% CI 0.17, 0.48; I²=0.0%; P<0.0001). This constitutes the strongest direct scientific evidence linking corrected iron stores to reduced fatigue independently of hemoglobin changes.

Lean meat and seafood are the richest dietary sources of heme iron, while nuts, beans, and vegetables contain nonheme iron; wheat and other flours are often fortified with iron, making bread, cereal, and other grain products good dietary sources of nonheme iron as well. Heme iron, derived from animal-based sources such as meat, poultry, and seafood, is highly bioavailable, with absorption rates of 25–30%; in contrast, nonheme iron, predominantly found in plant-based foods such as grains, legumes, and vegetables, has a much lower absorption rate of approximately 3–5%.

The bioavailability of iron is approximately 14–18% from mixed diets that include substantial amounts of meat, seafood, and vitamin C, and 5–12% from vegetarian diets.

Vitamin C (Ascorbic Acid)

Traditional use: Historically, vitamin C-rich foods (citrus, rosehips, and fresh vegetables) have been consumed alongside iron-rich meals in many cultural food traditions, a practice whose rationale was empirically derived long before the biochemical mechanism was identified.

Scientific evidence (strong): Vitamin C enhances iron absorption due to its ability to reduce ferric iron to ferrous iron via its antioxidant property, prevent conversion back to ferric iron, and its potential to chelate iron for enhancing absorption. This mechanism enhances iron absorption; a Cochrane review found that daily iron supplementation for pregnant women with vitamin C had a higher reduction in the prevalence of anemia than those supplemented with only iron; however, not much difference in hemoglobin or serum ferritin was observed.

A systematic review and meta-analysis on the regulation of dietary iron bioavailability by vitamin C found that the combined pooled effects showed a highly significant increase in percentage iron absorption when ascorbic acid was added to test meals, with a very low level of inconsistency (mean difference: 5.87; 95% CI 4.43, 7.31; P=0.00001; n=315 total study participants; I²=14%). The effect of vitamin C has been proven to be dose-dependent and can increase the absorption of iron only when both nutrients are consumed together. The WHO recommends the addition of fruits and vegetables rich in vitamin C to the diet to increase iron absorption. This represents robust, multi-study evidence; the effect on long-term iron status is more modest and context-dependent.

Other Key Dietary Co-factors

In addition to ascorbic acid, meat, poultry, and seafood can enhance nonheme iron absorption, whereas phytate (present in grains and beans) and certain polyphenols in some non-animal foods have the opposite effect. Unlike other inhibitors of iron absorption, calcium may reduce the bioavailability of both nonheme and heme iron. Avoiding beverages such as tea and coffee, and calcium-containing milk, during meals improves the absorption of non-heme iron.

Bran fibre, large amounts of calcium — particularly from supplements — and plant substances such as phytates and tannins can inhibit the absorption of non-heme iron.

Herbs and Natural Ingredients: Traditional Use and Scientific Evidence

Stinging Nettle (Urtica dioica)

Traditional use: Stinging Nettle (Urtica dioica) has been a cornerstone of traditional European herbalism for centuries, historically used as a spring tonic to cleanse the blood and restore vitality after winter. In this tradition, it was prepared as a tea, decoction, or cooked as a green vegetable, valued for its perceived blood-building properties.

Scientific evidence (weak to preliminary): Nettle leaf contains iron, vitamin C, and other minerals. Some laboratory analyses have shown that nettle can provide nutritional support, and it is sometimes included in herbal blends marketed for anemia; the presence of vitamin C in nettle may enhance non-heme iron absorption somewhat, but clinical trials specifically evaluating nettle's effects on anemia in humans are lacking; most available information relies on its nutritional profile and traditional use rather than rigorous clinical validation; in summary, while stinging nettle is traditionally used to support those with anemia due to its content of iron and other nutrients, there is only weak scientific evidence to support these claims. The scientific literature does not yet support specific clinical claims for nettle as an iron-deficiency fatigue remedy.

Yellow Dock (Rumex crispus)

Traditional use: Yellow dock (Rumex crispus) has been used in Western herbal traditions for centuries specifically to address iron deficiency. Yellow dock root is a classic Western herbal remedy for poor iron absorption; it contains iron and anthraquinone compounds that are thought to improve mineral assimilation from the diet.

Scientific evidence (very limited): Although yellow dock's iron content is not significant enough to have an effect on iron status, the plant's vitamin C content works with the body to better absorb nonheme iron; there is a lack of human clinical trials on yellow dock, and some animal and lab-based studies highlight the various potential health benefits of yellow dock's active constituents. No peer-reviewed human clinical trials demonstrating that yellow dock supplementation reduces iron-deficiency fatigue have been identified in the literature. Evidence remains at the level of in vitro and animal studies, with traditional use as the primary basis for its reputation.

Moringa (Moringa oleifera)

Traditional use: Moringa leaves have been used for centuries in traditional medicine in South Asia and parts of Africa as a nutritive food and tonic, particularly for women and children, where the plant is valued for its broad mineral and vitamin content.

Scientific evidence (emerging, limited): Emerging evidence from clinical studies suggests that Moringa oleifera may positively influence hemoglobin synthesis and red blood cell production, primarily by enhancing iron absorption and reducing oxidative stress, two key factors involved in the pathophysiology of anemia. A review of the literature found 12 studies meeting inclusion criteria from an initial pool, including a combined total of 1,084 participants from diverse regions, with moringa administered in various forms including leaf powder, extracts, capsules, and fortified foods. One small Pakistani interventional study enrolled 45 women of reproductive age with hemoglobin 8–11.9 g/dL and found that hemoglobin, mean corpuscular volume, MCH, and MCHC were highly significant (p<0.05) in the moringa and spirulina groups; Hb, MCH, and MCHC were significant in the combined group; moringa, spirulina, and their combined supplementation were equally effective in improving selected CBC parameters. However, this study was very small (only 30 completers), limiting generalizability. Animal model data show that dietary iron from moringa leaf was found to be superior compared with ferric citrate in overcoming the effects of iron deficiency in rats, though animal findings cannot be directly extrapolated to humans. Overall, the evidence base for moringa is preliminary and larger, well-controlled human trials are needed.

Spirulina (Arthrospira platensis)

Traditional use: Spirulina, a blue-green microalgae, has a long history of use as a food source in certain African and Mesoamerican cultures. Its use as a targeted nutritional supplement for anemia is a more modern practice rooted in its measured iron content.

Scientific evidence (limited, preliminary): Spirulina contains iron and has been studied in small trials. In the same Pakistani pilot study noted above, spirulina supplementation produced significant improvements in hemoglobin and red cell indices in women with iron-deficiency anemia, though the study's small size (10 completers per arm) and open design substantially limit conclusions. A randomized controlled trial in Kenya examined the impact of a spirulina corn-soy blend on iron-deficient children aged 6–23 months, with principal outcomes measuring between-arm differences in hematocrit status and recovery rates from iron deficiency anemia at end of intervention. The evidence base for spirulina as a specific therapy for iron-deficiency fatigue in adults is still limited and inconclusive; it is best characterized as an iron-containing food source with potential nutritional utility rather than a clinically validated remedy.

Ashwagandha (Withania somnifera)

Traditional use: Ashwagandha has a long history of being seen as a Rasayana (rejuvenating tonic) in Ayurvedic medicine for its ability to rejuvenate, adapt, and support longevity; according to the Charaka Samhita and Sushruta Samhita, ashwagandha is recommended for those suffering from weakness, tiredness, poor body weight, and neurological problems.

Scientific evidence (preliminary for hematopoietic effects; moderate for fatigue and performance): Pregnancy is associated with increased risk of anemia; ashwagandha root extract possesses adaptogenic and hematopoietic potential, but evidence in pregnant women is scarce. A prospective, randomized, open-label, 12-week trial enrolled 70 pregnant women in the second trimester; participants received either ashwagandha root extract 300 mg twice daily plus standard hematinic therapy, or standard hematinic therapy alone; primary endpoints included changes in hemoglobin and red blood cell indices.

Separately, ashwagandha has a more developed evidence base for general fatigue and physical performance. A systematic review and Bayesian meta-analysis of 13 clinical trials found ashwagandha is considered a potent adaptogen and anti-stress agent that could have potential to improve physical performance; the PRISMA-based review evaluated clinical trials from PubMed, ScienceDirect, and Google Scholar through 2020; a total of 13 studies met the requirements, and a low-to-moderate overall risk of bias was detected. The evidence for ashwagandha specifically reducing iron-deficiency fatigue (as opposed to general fatigue) is indirect and not yet established by dedicated trials. Its hematopoietic role in the context of iron deficiency remains preliminary.

Dandelion (Taraxacum officinale)

Traditional use: Dandelion root and leaf have long been employed in European and North American folk medicine as a nutritive bitter tonic, believed to support digestive function and liver health, which in turn was thought to improve nutrient assimilation including iron.

Scientific evidence: No peer-reviewed human clinical trials evaluating dandelion specifically for iron-deficiency fatigue or iron status were identified in the primary literature search. Its inclusion in herbal traditions for iron support appears to be based on its nutritional mineral content and its role as a bitter digestive stimulant rather than direct evidence of iron-raising efficacy in humans. Claims require further investigation.

Dietary and Lifestyle Factors

Dietary Pattern and Food Sources

Vegetarians should consume a diet including wholegrains, legumes, seeds, and green vegetables together with iron absorption enhancers. The Nordic Nutrition Recommendations 2023 state that iron absorption from foods is generally lower than that of most other nutrients and can vary between less than 2% and 50% depending on individual iron status and iron bioavailability in the meal.

About 25% of dietary heme iron is absorbed, while 17% or less of dietary non-heme iron is absorbed; iron bioavailability is estimated to be 14–18% for those consuming animal products and as low as 5–12% for plant-based eaters; heme iron contributes about 10–15% of total dietary iron intake in Western populations, but its higher bioavailability results in it being approximately 40% of the total iron absorbed.

Meal Composition and Enhancers

Strategic food pairing is an evidence-supported dietary strategy for optimizing non-heme iron absorption. In addition to ascorbic acid, meat, poultry, and seafood can enhance nonheme iron absorption, whereas phytate and certain polyphenols in some non-animal foods have the opposite effect. While heme iron absorption is efficient and resistant to dietary inhibitors such as phytates, non-heme iron absorption is influenced by both enhancers and inhibitors present in the diet.

Beverages and Timing

Avoiding beverages such as tea and coffee, and calcium-containing milk, during meals improves the absorption of non-heme iron. In addition, experts recommend taking calcium and iron supplements at different times to avoid potential interference with the absorption of iron.

Vegetarian and Vegan Diets

Heme iron has higher bioavailability than nonheme iron, and other dietary components have less effect on the bioavailability of heme than nonheme iron; the bioavailability of iron is approximately 14–18% from mixed diets that include substantial amounts of meat, seafood, and vitamin C, and 5–12% from vegetarian diets. This differential necessitates deliberate dietary planning for those following plant-based diets.

Pregnancy and Lactation

Women of reproductive age have a higher risk of developing iron deficiency due to the increased physiologic demand for iron required to support menstruation and pregnancy; iron deficiency can develop into iron deficiency anaemia, which affects one in three women between the ages of 15–49 worldwide; among women of reproductive age, those who are pregnant have the highest risk of developing iron deficiency and iron-deficiency anaemia due to increased iron requirements to support pregnancy and the developing fetus.

Physical Activity

Athletes and those performing in demanding sports have increased iron needs and are at a higher risk of developing iron deficiency, mainly due to chronic inflammation and increased losses; hepcidin levels are elevated in chronic inflammation, resulting in blockage of the only known iron exporter, ferroportin; athletes have greater iron losses through urine and sweat during vigorous activity. Exercise-induced increases in hepcidin — a hormone that suppresses dietary iron absorption — represent a documented mechanism by which endurance exercise may worsen iron status.

Inflammation and Chronic Disease

Ferritin is also elevated in the presence of inflammation, which means that in individuals with chronic inflammatory conditions, standard ferritin measurements may overestimate iron stores, potentially masking functional deficiency. Nutritional status and inflammation levels affect ferritin levels and may interfere with the correct diagnosis of iron deficiency in both vegetarian and omnivorous individuals.

Screening Considerations

The International Federation of Gynecology and Obstetrics and the European Hematology Association recommend screening all pregnant and reproductive-aged women for iron deficiency. Populations at high risk should be considered for prophylaxis with iron therapy; these groups include women with heavy menstrual cycles, frequent blood donors, adolescent girls, and people who eat strict vegetarian diets; empirical iron supplements for everyone are not recommended, as there is no evidence that this is beneficial and may be harmful.

Evidence Summary Table

• Iron repletion (therapeutic): Strong evidence from meta-analysis of 6 RCTs demonstrating significant reduction in fatigue in IDWA (pooled effect size 0.33, p<0.0001).
• Vitamin C co-administration: Strong mechanistic and trial evidence for enhancement of non-heme iron absorption; WHO endorses dietary vitamin C co-consumption. Effect on fatigue specifically is indirect.
• Moringa (M. oleifera): Emerging; small human trials and animal data are promising for hematological parameters. Evidence for fatigue specifically is lacking. Larger RCTs needed.
• Spirulina: Preliminary; small human trials show hematological improvements but sample sizes are very small. Iron-containing food source rather than validated remedy.
• Ashwagandha (W. somnifera): Moderate evidence for general fatigue/performance (meta-analysis); preliminary and indirect evidence only for hematopoietic benefit in iron deficiency contexts.
• Stinging Nettle (U. dioica): Weak evidence; nutritional profile and traditional use form the primary basis. No dedicated human RCTs for iron-deficiency fatigue.
• Yellow Dock (R. crispus): Very weak evidence; no human clinical trials identified. Based primarily on traditional use and in vitro/animal data.
• Dandelion (T. officinale): No peer-reviewed clinical trials identified for iron-deficiency fatigue. Traditional use only.

References

• Auerbach M, Munoz M. Iron-Deficiency Anemia. StatPearls. NCBI Bookshelf, NIH (Updated 2026)
• Elstrott B, et al. Iron Deficiency and Microcytic Hypochromic Anemia. StatPearls. NCBI Bookshelf, NIH (Updated 2026)
• National Heart, Lung, and Blood Institute (NHLBI). Iron-Deficiency Anemia. NIH
• NIH Office of Dietary Supplements. Iron: Health Professional Fact Sheet
• Soppi ET. Iron deficiency without anemia – a clinical challenge. Clinical Case Reports. 2018;6:1082–1086. PMC
• Cappellini MD, et al. Iron deficiency without anaemia: a diagnosis that matters. Clinical Medicine. 2021. PMC
• Yokoi K, Konomi A. Iron deficiency without anaemia is a potential cause of fatigue: meta-analyses of randomised controlled trials and cross-sectional studies. British Journal of Nutrition. 2017;117:1422–1431. PubMed
• Auerbach M, DeLoughery TG. Iron Deficiency in Adults: A Review. JAMA. 2025. PubMed
• Fehr J, et al. Iron deficiency, Fatigue and Restless-Legs-Syndrome. Praxis (Bern). 2016. PubMed
• Czarny P, et al. Chronic Fatigue Syndrome in Patients with Deteriorated Iron Metabolism. PMC. 2022
• Galy B, et al. Iron Deficiency without Anemia Decreases Physical Endurance and Mitochondrial Complex I Activity of Oxidative Skeletal Muscle in the Mouse. PMC. 2021
• Bhatt DL, et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. PNAS. 2016. PMC
• Abbaspour N, et al. Dietary Iron. StatPearls. NCBI Bookshelf, NIH
• Dietary Heme Iron: A Review of Efficacy, Safety and Tolerability. Nutrients. 2025. PMC
• Thankachan P, et al. Treatment efficacy of vitamin C or ascorbate given as co-intervention with iron for anemia – A systematic review and meta-analysis. Clinical Nutrition ESPEN. 2023
• Hallberg L, et al. The Regulation of Dietary Iron Bioavailability by Vitamin C: A Systematic Review and Meta-Analysis. Proceedings of the Nutrition Society. 2017
• Sartain S, et al. Iron deficiency and fatigue in inflammatory bowel disease: A systematic review. PLOS ONE. 2025. PMC
• Soppi E. Non-anaemic iron deficiency. British Journal of General Practice. 2022. PMC
• Mantovani LF, et al. Iron Deficiency in Vegetarian and Omnivorous Individuals: Analysis of 1340 Individuals. PMC. 2021
• Hallberg L, Hulthén L. Iron — a background article for the Nordic Nutrition Recommendations 2023. PMC. 2024
• Barney J, et al. Iron deficiency and iron deficiency anaemia in women of reproductive age: Sex- and gender-based risk factors and inequities. Journal of Trace Elements in Medicine and Biology. 2025
• Singh A, et al. Efficacy and safety of Ashwagandha root extract in pregnant women: a prospective, randomized, comparative, open-label, 12-week study. PMC. 2025
• Pérez-Gómez J, et al. Effects of Ashwagandha on Physical Performance: Systematic Review and Bayesian Meta-Analysis. PMC. 2021
• Smith N. Integrative Nutrition: Herbal Therapies to Treat Iron-Deficiency Anemia. Today's Dietitian. November 2022
• Arredondo M, et al. Iron deficiency in non-pregnant women with normal hemoglobin: a cross-sectional analysis of risk factors and clinical implications. PMC. 2025
• Asante M, et al. Dietary iron supplements and Moringa oleifera leaves influence the liver hepcidin messenger RNA expression and biochemical indices of iron status in rats. Nutrition Research. 2014. PubMed
• Rathod JR, et al. Efficacy of Plant-Based Iron and Vitamin C in Adults With Iron Deficiency Anemia: A Randomized, Double-Blind Clinical Study. PMC. 2025